These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1329 related items for PubMed ID: 21885126

  • 1. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 2. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.
    Greathouse MK, Weir MR.
    Postgrad Med; 2012 Mar; 124(2):40-52. PubMed ID: 22437214
    [Abstract] [Full Text] [Related]

  • 3. Long-term antihypertensive efficacy of losartan/hydrochlorothiazide combination therapy on home blood pressure control.
    Miyagawa S, Yamada H, Matsubara H.
    Clin Exp Hypertens; 2012 Mar; 34(6):439-46. PubMed ID: 22471874
    [Abstract] [Full Text] [Related]

  • 4. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 5. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM.
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 8. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H, Shimada Y, Fujiwara K.
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM.
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive medication changes and blood pressure goal achievement in a managed care population.
    Engel-Nitz NM, Darkow T, Lau H.
    J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489
    [Abstract] [Full Text] [Related]

  • 12. Patient satisfaction with antihypertensive therapy.
    Chen K, Chiou CF, Plauschinat CA, Frech F, Harper A, Dubois R.
    J Hum Hypertens; 2005 Oct; 19(10):793-9. PubMed ID: 15951740
    [Abstract] [Full Text] [Related]

  • 13. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Oct; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 14. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
    Metoki H, Ohkubo T, Kikuya M, Asayama K, Inoue R, Obara T, Hirose T, Sato M, Hashimoto T, Imai Y, J-HOME-AI Study group.
    J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 16. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
    Boersma C, Voors AA, Visser ST, de Jong-van den Berg LT, Postma MJ.
    Am J Cardiovasc Drugs; 2010 Sep; 10(1):49-54. PubMed ID: 20104934
    [Abstract] [Full Text] [Related]

  • 18. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E.
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [Abstract] [Full Text] [Related]

  • 19. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M, Hosoai H, Ikewaki K, Ayaori M, Yamashita T, Shige H, Higashi K, Nashida Y, Shimizu S, Kijima F, Yokoyama M, Nakamura H, ABC Study Group.
    Clin Ther; 2013 Apr 06; 35(4):461-73. PubMed ID: 23490288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.